ArticleCureus2026
Unilateral Panuveitis Secondary to Toxoplasmosis in an Immunocompromised Patient: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Panuveitis is a severe form of intraocular inflammation involving the anterior chamber, vitreous, retina, or choroid, with potential for significant visual morbidity. Differentiating between infectious and non-infectious aetiologies is particularly challenging in immunosuppressed patients, where clinical features may overlap. We report the case of a 54-year-old male patient with rheumatoid arthritis on systemic immunosuppression who presented with unilateral right eye panuveitis. Multimodal imaging was essential in characterising disease activity and monitoring response to treatment. Although initial investigations raised the possibility of ocular sarcoidosis, the overall clinical and imaging findings were more consistent with a presumptive diagnosis of ocular toxoplasmosis. This highlights the limitations of serological testing in immunocompromised individuals. The patient achieved clinical quiescence with residual vitreous changes and stable retinal findings. This case highlights the importance of comprehensive evaluation and multimodal imaging in distinguishing between infectious and inflammatory causes of panuveitis and guiding appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.